These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 4698395)
61. Human hypoxanthine (guanine) phosphoribosyltransferase: an amino acid substitution in a mutant form of the enzyme isolated from a patient with gout. Wilson JM; Tarr GE; Kelley WN Proc Natl Acad Sci U S A; 1983 Feb; 80(3):870-3. PubMed ID: 6572373 [TBL] [Abstract][Full Text] [Related]
62. An enzymatic basis for variation in response to allopurinol. Hypoxanthine-guanine phosphoribosyltransferase deficiency. Kelley WN; Rosenbloom FM; Miller J; Seegmiller JE N Engl J Med; 1968 Feb; 278(6):287-93. PubMed ID: 5638346 [No Abstract] [Full Text] [Related]
63. Purine metabolism in women with primary gout. Puig JG; Mateos FA; Miranda ME; Torres RJ; de Miguel E; Pérez de Ayala C; Gil AA Am J Med; 1994 Oct; 97(4):332-8. PubMed ID: 7942934 [TBL] [Abstract][Full Text] [Related]
64. Studies on the biochemical actions of 6-selenoguanine and 6-selenoguanosine. Ross AF; Agarwal KC; Chu SH; Parks RE Biochem Pharmacol; 1973 Jan; 22(2):141-54. PubMed ID: 4763250 [No Abstract] [Full Text] [Related]
65. Alpha-5-phosphoribosyl-1-pyrophosphate-independent salvage of purines in cultured Chinese hamster lung fibroblasts. Camici M; Mura U; Cellini F; Del Corso A; Turchi G; Ipata PL Arch Biochem Biophys; 1988 Sep; 265(2):234-40. PubMed ID: 2458698 [TBL] [Abstract][Full Text] [Related]
66. Altered kinetic property of erythrocyte phosphoribosylpsyrophosphate synthetase in excessive purine production. Sperling O; Boer P; Persky-Brosh S; Kanarek E; De Vries A Rev Eur Etud Clin Biol; 1972; 17(7):703-6. PubMed ID: 4346548 [No Abstract] [Full Text] [Related]
68. Hypoxanthine-guanine phosphoribosyl transferase: assay using high performance liquid chromatography. Rylance HJ; Wallace RC; Nuki G Clin Chim Acta; 1982 May; 121(2):159-65. PubMed ID: 7094337 [TBL] [Abstract][Full Text] [Related]
69. Analysis of the genotypes for aldehyde dehydrogenase 2 in Japanese patients with primary gout. Yamanaka H; Kamatani N; Hakoda M; Terai C; Kawaguchi R; Kashiwazaki S Adv Exp Med Biol; 1994; 370():53-6. PubMed ID: 7660963 [TBL] [Abstract][Full Text] [Related]
70. [Clearance of oxypurines and uric acid in patients with gout]. Vannoni D; Porcelli B; Di Stefano A; Pizzichini M; Leoncini R; Terzuoli L; Taddeo A; Marsini S; Morozzi G; Marcolongo R Medicina (Firenze); 1989; 9(3):297-9. PubMed ID: 2615606 [TBL] [Abstract][Full Text] [Related]
71. A distinct human variant of hypoxanthine-guanine phosphoribosyl transferase. Sweetman L; Hoch MA; Bakay B; Borden M; Lesh P; Nyhan WL J Pediatr; 1978 Mar; 92(3):385-9. PubMed ID: 632976 [TBL] [Abstract][Full Text] [Related]
72. Kelley-Seegmiller syndrome due to a unique variant of hypoxanthine-guanine phosphoribosyltransferase: reduced affinity for 5-phosphoribosyl-1-pyrophosphate manifested only at low, physiological substrate concentrations. Zoref-Shani E; Feinstein S; Frishberg Y; Bromberg Y; Sperling O Biochim Biophys Acta; 2000 Feb; 1500(2):197-203. PubMed ID: 10657589 [TBL] [Abstract][Full Text] [Related]
73. Dietary-induced variation of hypoxanthine-guanine phosphoribosyl transferase activity in patients with the Lesch-Nyhan syndrome. Arnold WJ; Kelley WN J Clin Invest; 1973 Apr; 52(4):970-3. PubMed ID: 4693659 [TBL] [Abstract][Full Text] [Related]
74. [Partial defect in hypoxanthine-guanine phosphorisbosiltransferase in Berger's disease in a young gout patient]. Rapado A; Díaz Curiel M; López García A; Castrillo JM; Ruíz Palomo F Rev Clin Esp; 1977 Oct; 147(1):85-8. PubMed ID: 928880 [No Abstract] [Full Text] [Related]
75. [Metabolism of purine nucleotides in the central nervous system in patients with phosphoribosylpyrophosphate synthetase hyperactivity and neurosensory deafness]. López Jiménez M; García Puig J; Mateos Antón F; Ramos Hernández T; Sebastián Melián J; García Neito V Neurologia; 1990 Jan; 5(1):14-7. PubMed ID: 2163266 [TBL] [Abstract][Full Text] [Related]